An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours

NCT01541930 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Malodorous Infected Cutaneous Ulcer

Interventions

DRUG: GK567

Sponsor

Galderma R&D